Examination of prognostic factors in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Suzuna SugiMasaki TominagaShinjiro KaiedaKiminori FujimotoTomonori ChikasueTakuma KogaYuri HasuoErina IwanagaKenta MurotaniJamie Kristen T LimHiroaki IdaTomotaka KawayamaTomoaki HoshinoPublished in: Modern rheumatology (2024)
Four weeks after starting the treatment, serum C-reactive protein and albumin levels of patients with MDA5-DM can be used to evaluate treatment response and predict prognosis.